| Manon Loonis, | |
|
1493 Cambridge St, Cambridge, MA 02139-1099 | |
| (617) 665-1000 | |
| Not Available |
| Full Name | Manon Loonis |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1493 Cambridge St, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023570868 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 1016850 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Manon Loonis, 1493 Cambridge St, Cambridge, MA 02139-1099 Ph: (617) 665-1000 | Manon Loonis, 1493 Cambridge St, Cambridge, MA 02139-1099 Ph: (617) 665-1000 |
News Archive
Electron-beam computed tomography (EBCT) is more accurate than conventional catheter angiography for detecting a dangerous congenital heart abnormality that could cause sudden death, according to research by a Saint Louis University radiologist published last month in Catheterization and Cardiovascular Interventions: Journal of the Society for Cardiovascular Angiography and Interventions.
DARA BioSciences, Inc. today announced that, on May 28 2010, NASDAQ notified the Company that it has regained compliance with the minimum bid price requirement as set forth in NASDAQ Listing Rule 5550(a)(2). On May 26, 2010, the Company's closing bid price was $3.58 per share, the tenth consecutive day it had been above $1 per share.
Reuters reports that the health care sector will be "a focal point" for years to come and looks at investments in companies that are likely to make money by helping to reduce costs. Meanwhile, Kaiser Health News examines whether competitive health care models like Medicare Part D and the Federal Employees Health Benefits program are taming costs as effectively as supporters suggest.
The brain plays a central role in regulating appetite and whole-body metabolism. A protein known as PPARĪ³ is important in the brain's control of food intake and body weight, but the identity of the neurons regulating this process has been unclear.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
› Verified 9 days ago
Dr. Benjamin Kerman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-499-5025 Fax: 617-864-0085 | |
Dr. Luis F Lobon, M.D., M.S. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1712 Fax: 617-665-3145 | |
Allen Mario Poma, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 150 Vassal Ln, Cambridge, MA 02138 Phone: 617-714-5663 | |
Laura G Ebbeling, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-499-5025 | |
Dr. Hannah Bach, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 231-409-2511 | |
Benjamin T Milligan, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-2113 |